Isabelle Kaiser

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Randomized Controlled Trial

Systematic Review

Magnetic Resonance

Top Venues

Current oncology (Toronto, Ont.)

Journal of clinical medicine

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Olaf Gefeller, Isabelle Kaiser, Emily M Brockmann, Wolfgang Uter, Annette B Pfahlberg
The Level of Agreement between Self-Assessments and Examiner Assessments of Melanocytic Nevus Counts: Findings from an Evaluation of 4548 Double Assessments. Current oncology (Toronto, Ont.) 31 (4) (2024)
Olaf Gefeller, Isabelle Kaiser, Emily M Brockmann, Wolfgang Uter, Annette B Pfahlberg
The Level of Agreement between Self-Assessments and Examiner Assessments of Melanocytic Nevus Counts: Findings from an Evaluation of 4548 Double Assessments. Current oncology (Toronto, Ont.) 31 (4) (2024)
Olaf Gefeller, Isabelle Kaiser, Emily M Brockmann, Wolfgang Uter, Annette B Pfahlberg
The Level of Agreement between Self-Assessments and Examiner Assessments of Melanocytic Nevus Counts: Findings from an Evaluation of 4548 Double Assessments. Current oncology (Toronto, Ont.) 31 (4) (2024)
Olaf Gefeller, Isabelle Kaiser, Emily M Brockmann, Wolfgang Uter, Annette B Pfahlberg
The Level of Agreement between Self-Assessments and Examiner Assessments of Melanocytic Nevus Counts: Findings from an Evaluation of 4548 Double Assessments. Current oncology (Toronto, Ont.) 31 (4) (2024)
Sonja Mathes, Karla S Lindwedel, Lill Tove Nilsen, Isabelle Kaiser, Annette B Pfahlberg, Olaf Gefeller
Global Tanning Bed Advertising: A Comparison of Legal Regulations on Three Continents. Cancers 15 (17) (2023)
Isabelle Kaiser, Annette B Pfahlberg, Sonja Mathes, Wolfgang Uter, Katharina Diehl, Theresa Steeb, Markus Vincent Heppt, Olaf Gefeller
Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training. Journal of clinical medicine 12 (5) (2023)
Isabelle Kaiser, Annette B Pfahlberg, Sonja Mathes, Wolfgang Uter, Katharina Diehl, Theresa Steeb, Markus Vincent Heppt, Olaf Gefeller
Inter-Rater Agreement in Assessing Risk of Bias in Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST): Results from a Controlled Experiment on the Effect of Specific Rater Training. Journal of clinical medicine 12 (5) (2023)
Isabelle Kaiser, Sonja Mathes, Annette B Pfahlberg, Wolfgang Uter, Carola Berking, Markus Vincent Heppt, Theresa Steeb, Katharina Diehl, Olaf Gefeller
Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) to Evaluate Melanoma Prediction Studies. Cancers 14 (12) (2022)
Isabelle Kaiser, Katharina Diehl, Markus Vincent Heppt, Sonja Mathes, Annette B Pfahlberg, Theresa Steeb, Wolfgang Uter, Olaf Gefeller
Reporting Quality of Studies Developing and Validating Melanoma Prediction Models: An Assessment Based on the TRIPOD Statement. Healthcare (Basel, Switzerland) 10 (2) (2022)
Isabelle Kaiser, Annette B Pfahlberg, Wolfgang Uter, Markus Vincent Heppt, Marit Bragelien Veierød, Olaf Gefeller
Risk Prediction Models for Melanoma: A Systematic Review on the Heterogeneity in Model Development and Validation. International journal of environmental research and public health 17 (21) (2020)